Skip to main content

Table 4 Vaccine coverage and reasons for non-vaccination of European patients*

From: Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross-sectional and comparative study

 

Spain

(232)

Portugal

(184)

UK/Ireland

(151)

France

(82)

Italy

(59)

All patients

(744)

Influenza

116 (50)

79 (42.9)

112 (74.2)

26 (31.7)

13 (22)

367 (49.3)

Pneumococcal

72 (31)

53 (28.8)

74 (49)

47 (57.3)

8 (13.6)

271 (36.4)

Influenza and pneumococcal

59 (25.4)

38 (20.7)

69 (45.7)

21 (25.6)

5 (8.5)

202 (27.2)

Tetanus

84 (36.2)

123 (66.8)

66 (43.7)

53 (64.6)

18 (30.5)

366 (49.2)

No influenza and no pneumococcal

103 (44.4)

90 (48.9)

34 (22.5)

30 (36.6)

37 (62.7)

308 (41.4)

Incomplete vaccination a

202 (87.1)

174 (94.6)

113 (74.8)

67 (81.7)

56 (94.9)

620 (83.3)

Lack of medical prescription b

143 (70.8)

99 (56.9)

76 (67.3)

25 (37.3)

34 (60.7)

392 (63.2)

Rejection by patients b

26 (12.9)

25 (14.4)

17 (15)

27 (40.3)

12 (21.4)

114 (18.4)

Not available/ cost issues b

7 (3.5)

5 (2.9)

10 (8.8)

3 (4.5)

1 (1.8)

26 (4.2)

Others b

34 (16.8)

29 (16.7)

15 (13.3)

15 (22.4)

9 (16.1)

110 (17.7)

  1. * Except where indicated otherwise, values are the number (%) of patients
  2. ** Other participating countries: Belgium (12 patients), Netherlands (6 patients), Luxembourg (4 patients), Denmark (3 patients), Germany (2 patients), Greece (2 patients), Switzerland (2 patients), Andorra (1 patient), Croatia (1 patient), Cyprus (1 patient), Iceland (1 patient), Norway (1 patient)
  3. aIncludes those who reported not having received at least one of the vaccines (influenza, pneumonia or tetanus)
  4. bThe percentage was calculated using the number of non-vaccinated as the denominator